
Videos








A 58-Year-Old Woman with Polycythemia Vera

Ahmed Omar Kaseb, MD, associate professor of Gastrointestinal Medical Oncology at The University of Texas MD Anderson Cancer Center, says 2 major challenges in hepatocellular carcinoma are the lack of effective treatments and the co-existing underlying chronic liver disease.







A Case of HR+ Metastatic Breast Cancer






JAK Inhibition for the Management of Primary Myelofibrosis







Primary Myelofibrosis

Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
Phase 3 Data Highlight Orca-T’s Clinical Benefits in Heme Malignancies
2
ctDNA Assay Offers Prognostic Insights for Immunotherapy-Treated Solid Tumors
3
FDA Grants Regular Approval to Rucaparib for BRCA-Mutated mCRPC
4
ctDNA Refines Risk in Neoadjuvant-Resistant Breast Cancer
5

